Viral Load Reduction and High-Dose Ivermectin in Early Treatment: A Reappraisal

Int J Antimicrob Agents. 2022 May;59(5):106575. doi: 10.1016/j.ijantimicag.2022.106575. Epub 2022 Mar 20.

Authors

Simone Tedeschi¹, Luigi Ventura²

Affiliations

¹ University of Cassino and Southern Lazio, Cassino, Italy.
² Sapienza University of Rome, Rome, Italy.

PMID: 35322790
DOI: 10.1016/j.ijantimicag.2022.106575

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Ivermectin* / therapeutic use
SARS-CoV-2
Viral Load

Substances

Ivermectin